Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush

Journal of Neuroinflammation

Volumn 11, Issue 1, 2014, Pages

  Mac Nair, Caitlin E ^a,b   Fernandes, Kimberly A ^c   Schlamp, Cassandra L ^a   Libby, Richard T ^c   Nickells, Robert W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Macroglia; Neuroinflammation; Retinal ganglion cell; Secondary degeneration; TNF

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN C JUN; TUMOR NECROSIS FACTOR; NEUROPROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; KINETICS; MACROGLIA; MICROGLIA; MOUSE; MUELLER CELL; NERVE CELL NECROSIS; NERVE CRUSH; NEUROPROTECTION; NONHUMAN; OPTIC NERVE INJURY; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REPORTER GENE; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; WILD TYPE; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; OPTIC NERVE INJURIES; PATHOLOGY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE CRUSH; NEUROPROTECTIVE AGENTS; OPTIC NERVE INJURIES; RETINAL GANGLION CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84965191178     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-014-0194-3     Document Type: Article

References (88)

1. Whitmore AV, Libby RT, John SW: Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes? Prog Retin Eye Res 2005, 24:639-662.
2. Nickells RW: From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can J Ophthalmol 2007, 42:278-287.
3. Nickells RW: Ganglion cell death in glaucoma: from mice to men. Vet Ophthalmol 2007, 10(Suppl 1):88-94.
4. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ: Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995, 36:774-786.
5. Li Y, Schlamp CL, Nickells RW: Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci 1999, 40:1004-1008.
6. Nickells RW: Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol 1999, 43(Suppl 1):S151-S161.
7. Yoles E, Muller S, Schwartz M: NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma 1997, 14:665-675.
8. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheeler LA, Schwartz M, Yoles E: RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci 2000, 41:4169-4174.
9. Li Y, Semaan SJ, Schlamp CL, Nickells RW: Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci 2007, 8:19.
10. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS: Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res 1996, 18:176-184.
11. Tezel G, Yang X, Yang J, Wax MB: Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in mice. Brain Res 2004, 996:202-212.
12. Zhang S, Wang H, Lu Q, Qing G, Wang N, Wang Y, Li S, Yang D, Yan F: Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension. Brain Res 2009, 1303:131-143.
13. Fitzgerald M, Bartlett CA, Harvey AR, Dunlop SA: Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study. J Neurotrauma 2010, 27:439-452.
14. Sivakumar V, Foulds WS, Luu CD, Ling EA, Kaur C: Retinal ganglion cell death is induced by microglia derived pro-inflammatory cytokines in the hypoxic neonatal retina. J Pathol 2011, 224:245-260.
15. Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A: The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res 2012, 31:152-181.
16. Lehmann U, Heuss ND, McPherson SW, Roehrich H, Gregerson DS: Dendritic cells are early responders to retinal injury. Neurobiol Dis 2010, 40:177-184.
17. Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P: Expression of acute-phase response proteins in retinal Muller cells in diabetes. Invest Ophthalmol Vis Sci 2005, 46:349-357.
18. Templeton JP, Freeman NE, Nickerson JM, Jablonski MM, Rex TS, Williams RW, Geisert EE: Innate immune network in the retina activated by optic nerve crush. Invest Ophthalmol Vis Sci 2013, 54:2599-2606.
19. Garcia M, Vecino E: Role of Muller glia in neuroprotection and regeneration in the retina. Histol Histopathol 2003, 18:1205-1218.
20. Bosco A, Steele MR, Vetter ML: Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 2011, 519:599-620.
21. Wax MB, Tezel G: Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res 2009, 88:825-830.
22. Baltmr A, Duggan J, Nizari S, Salt TE, Cordeiro MF: Neuroprotection in glaucoma-is there a future role? Exp Eye Res 2010, 91:554-566.
23. Tezel G, Wax MB: Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000, 20:8693-8700.
24. Dvoriantchikova G, Barakat D, Brambilla R, Agudelo C, Hernandez E, Bethea JR, Shestopalov VI, Ivanov D: Inactivation of astroglial NF-kappa B promotes survival of retinal neurons following ischemic injury. Eur J Neurosci 2009, 30:175-185.
25. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME: Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 2001, 42:975-982.
26. Levkovitch-Verbin H, Dardik R, Vander S, Melamed S: Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve. Exp Eye Res 2010, 91:127-134.
27. Yoles E, Schwartz M: Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol 1998, 42:367-372.
28. Lebrun-Julien F, Duplan L, Pernet V, Osswald I, Sapieha P, Bourgeois P, Dickson K, Bowie D, Barker PA, Di Polo A: Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism. J Neurosci 2009, 29:5536-5545.
29. Baptiste DC, Powell KJ, Jollimore CA, Hamilton C, LeVatte TL, Archibald ML, Chauhan BC, Robertson GS, Kelly ME: Effects of minocycline and tetracycline on retinal ganglion cell survival after axotomy. Neuroscience 2005, 134:575-582.
30. Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML: Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2 J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008, 49:1437-1446.
31. Levkovitch-Verbin H, Kalev-Landoy M, Habot-Wilner Z, Melamed S: Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol 2006, 124:520-526.
32. Kuchtey J, Rezaei KA, Jaru-Ampornpan P, Sternberg P Jr, Kuchtey RW: Multiplex cytokine analysis reveals elevated concentration of interleukin-8 in glaucomatous aqueous humor. Invest Ophthalmol Vis Sci 2010, 51:6441-6447.
33. Kerschensteiner M, Meinl E, Hohlfeld R: Neuro-immune crosstalk in CNS diseases. Results Probl Cell Differ 2010, 51:197-216.
34. Yuan L, Neufeld AH: Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000, 32:42-50.
35. Tezel G, Li LY, Patil RV, Wax MB: TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001, 42:1787-1794.
36. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW, Benowitz LI: Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006, 26:12633-12641.
37. Yang X, Luo C, Cai J, Powell DW, Yu D, Kuehn MH, Tezel G: Neurodegenerative and inflammatory pathway components linked to TNF-alpha/TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol Vis Sci 2011, 52:8442-8454.
38. Tezel G: TNF-alpha signaling in glaucomatous neurodegeneration. Prog Brain Res 2008, 173:409-421.
39. de Kozak Y, Naud MC, Bellot J, Faure JP, Hicks D: Differential tumor necrosis factor expression by resident retinal cells from experimental uveitis-susceptible and-resistant rat strains. J Neuroimmunol 1994, 55:1-9.
40. Kitaoka Y, Kitaoka Y, Kwong JM, Ross-Cisneros FN, Wang J, Tsai RK, Sadun AA, Lam TT: TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 2006, 47:1448-1457.
41. Roh M, Zhang Y, Murakami Y, Thanos A, Lee SC, Vavvas DG, Benowitz LI, Miller JW: Etanercept, a widely used inhibitor of tumor necrosis factor-alpha (TNF-alpha): prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One 2012, 7:e40065.
42. Husain S, Liou GI, Crosson CE: Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-alpha in the retina. Invest Ophthalmol Vis Sci 2011, 52:2577-2583.
43. Fontaine V, Mohand-Said S, Hanoteau N, Fuchs C, Pfizenmaier K, Eisel U: Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J Neurosci 2002, 22:RC216.
44. Howell GR, Walton DO, King BL, Libby RT, John SW: Datgan, a reusable software system for facile interrogation and visualization of complex transcription profiling data. BMC Genomics 2011, 12:429.
45. Reichstein D, Ren L, Filippopoulos T, Mittag T, Danias J: Apoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma. Exp Eye Res 2007, 84:13-21.
46. Madigan MC, Rao NS, Tenhula WN, Sadun AA: Preliminary morphometric study of tumor necrosis factor-alpha (TNF alpha)-induced rabbit optic neuropathy. Neurol Res 1996, 18:233-236.
47. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL: Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation: essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem2004, 279:32869-32881.
48. Veroni C, Gabriele L, Canini I, Castiello L, Coccia E, Remoli ME, Columba-Cabezas S, Arico E, Aloisi F, Agresti C: Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways. Mol Cell Neurosci 2010, 45:234-244.
49. Magness ST, Jijon H, Van Houten FN, Sharpless NE, Brenner DA, Jobin C: In vivo pattern of lipopolysaccharide and anti-CD3-induced NF-kappa B activation using a novel gene-targeted enhanced GFP reporter gene mouse. J Immunol 2004, 173:1561-1570.
50. Fernandes KA, Harder JM, Fornarola LB, Freeman RS, Clark AF, Pang IH, John SW, Libby RT: JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol Dis 2012, 46:393-401.
51. Fernandes KA, Harder JM, Kim J, Libby RT: JUN regulates early transcriptional responses to axonal injury in retinal ganglion cells. Exp Eye Res 2013, 112C:106-117.
52. Janssen KT, Mac Nair CE, Dietz JA, Schlamp CL, Nickells RW: Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis. Invest Ophthalmol Vis Sci 2013, 54:1805-1815.
53. Schlamp CL, Montgomery AD, Mac Nair CE, Schuart C, Willmer DJ, Nickells RW: Evaluation of the percentage of ganglion cells in the ganglion cell layer of the rodent retina. Mol Vis 2013, 19:1387-1396.
54. Li Y, Schlamp CL, Poulsen KP, Nickells RW: Bax-dependent and independent pathways of retinal ganglion cell death induced by different damaging stimuli. Exp Eye Res 2000, 71:209-213.
55. Nadal-Nicolas FM, Jimenez-Lopez M, Salinas-Navarro M, Sobrado-Calvo P, Alburquerque-Bejar JJ, Vidal-Sanz M, Agudo-Barriuso M: Whole number, distribution and co-expression of brn3 transcription factors in retinal ganglion cells of adult albino and pigmented rats. PLoS One 2012, 7:e49830.
56. Pelzel HR, Schlamp CL, Nickells RW: Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci 2010, 11:62.
57. Buckingham BP, Inman DM, Lambert W, Oglesby E, Calkins DJ, Steele MR, Vetter ML, Marsh-Armstrong N, Horner PJ: Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J Neurosci 2008, 28:2735-2744.
58. Soto I, Oglesby E, Buckingham BP, Son JL, Roberson ED, Steele MR, Inman DM, Vetter ML, Horner PJ, Marsh-Armstrong N: Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J Neurosci 2008, 28:548-561.
59. Schlamp CL, Johnson EC, Li Y, Morrison JC, Nickells RW: Changes in Thy1 gene expression associated with damaged retinal ganglion cells. Mol Vis 2001, 7:192-201.
60. Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, John SW: Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 2005, 1:17-26.
61. Nickells RW, Semaan SJ, Schlamp CL: Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death. Prog Brain Res 2008, 173:423-435.
62. Weishaupt JH, Klocker N, Bahr M: Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells. J Mol Neurosci 2005, 26:17-25.
63. Harder JM, Libby RT: BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina. Mol Neurodegener 2011, 6:50.
64. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF: Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J Immunol 1990, 144:129-135.
65. Merrill JE: Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci 1991, 13:130-137.
66. Ganter S, Northoff H, Mannel D, Gebicke-Harter PJ: Growth control of cultured microglia. J Neurosci Res 1992, 33:218-230.
67. Kuno R, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A: Autocrine activation of microglia by tumor necrosis factor-alpha. J Neuroimmunol 2005, 162:89-96.
68. Dhandapani KM, Hadman M, De Sevilla L, Wade MF, Mahesh VB, Brann DW: Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway. J Biol Chem 2003, 278:43329-43339.
69. Liu J, Minemoto Y, Lin A: c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 2004, 24:10844-10856.
70. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, Herrlich P: Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993, 12:3879-3891.
71. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, Li Z, Evans DB, Abbruzzese JL, Chiao PJ: NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 2004, 24:7806-7819.
72. Dann SG, Allison WT, Veldhoen K, Johnson T, Hawryshyn CW: Chromatin immunoprecipitation assay on the rainbow trout opsin proximal promoters illustrates binding of NF-kappaB and c-jun to the SWS1 promoter in the retina. Exp Eye Res 2004, 78:1015-1024.
73. Maggirwar SB, Ramirez S, Tong N, Gelbard HA, Dewhurst S: Functional interplay between nuclear factor-kappaB and c-Jun integrated by coactivator p300 determines the survival of nerve growth factordependent PC12 cells. J Neurochem 2000, 74:527-539.
74. Mizrahi K, Kagan S, Stein J, Yaniv I, Zipori D, Askenasy N: Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFkappaB with a characteristic transcriptional signature. Stem Cells Dev 2013, 6:676-686.
75. Varfolomeev EE, Ashkenazi A: Tumor necrosis factor: an apoptosis JuNKie? Cell 2004, 116:491-497.
76. Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, Lee S, Coorey NJ, Killingsworth M, Sherman LS, Gillies MC: Conditional Muller cell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 2012, 32:15715-15727.
77. Le RD, Rayner K, Rex M, Wigmore PM, Scotting PJ: The transcription factor cSox2 and neuropeptide Y define a novel subgroup of amacrine cells in the retina. J Anat 2002, 200:51-56.
78. Lin YP, Ouchi Y, Satoh S, Watanabe S: Sox2 plays a role in the induction of amacrine and Muller glial cells in mouse retinal progenitor cells. Invest Ophthalmol Vis Sci 2009, 50:68-74.
79. Schwartz M, Belkin M, Yoles E, Solomon A: Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration. J Glaucoma 1996, 5:427-432.
80. Bartsch JW, Wildeboer D, Koller G, Naus S, Rittger A, Moss ML, Minai Y, Jockusch H: Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J Neurosci 2010, 30:12210-12218.
81. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G: Do transient ischemic attacks have a neuroprotective effect? Neurology 2000, 54:2089-2094.
82. Saha RN, Ghosh A, Palencia CA, Fung YK, Dudek SM, Pahan K: TNF-alpha preconditioning protects neurons via neuron-specific up-regulation of CREB-binding protein. J Immunol 2009, 183:2068-2078.
83. Naude PJ, den Boer JA, Luiten PG, Eisel UL: Tumor necrosis factor receptor cross-talk. FEBS J 2011, 278:888-898.
84. Bender LM, Morgan MJ, Thomas LR, Liu ZG, Thorburn A: The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm. Cell Death Differ 2005, 12:473-481.
85. Dvoriantchikova G, Ivanov D: Tumor necrosis factor-alpha mediates activation of NF-kappaB and JNK signaling cascades in retinal ganglion cells and astrocytes in opposite ways. Eur J Neurosci 2014, 8:3171-3178.
86. Yan X, Tezel G, Wax MB, Edward DP: Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol 2000, 118:666-673.
87. Heuss ND, Pierson MJ, Montaniel KR, McPherson SW, Lehmann U, Hussong SA, Ferrington DA, Low WC, Gregerson DS: Retinal dendritic cell recruitment, but not function, was inhibited in MyD88 and TRIF deficient mice. J Neuroinflammation 2014, 11:143.
88. Angel P, Hattori K, Smeal T, Karin M: The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 1988, 55:875-885.